Chemed price to free cash flow CHE

Market value divided by free cash flow over the last twelve months, since 2011.

Today, Oct 23, 2026: 20.7×
10-year median: 27.0×
Against its 10-year history: 25th; percentile: 0 is its lowest day, 100 its highest
10-year range: 14.8× to 58.4×
Peer median: 21.6×

Chemed's price to free cash flow is 20.7× as of Oct 23, 2026.

That is below its ten-year median of 27.0×, lower than on 75% of days in the last ten years.

Over that time it ranged from 14.8× in Jun 2026 to 58.4× in May 2018.

The median for 10 hospital and care facility stocks of a similar size is 21.6×.

Price to free cash flow over time

median 27×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	20.7×	14.8×	22.3×
2025	17.0×	16.4×	26.9×
2024	25.1×	25.1×	36.3×
2023	34.1×	26.9×	40.7×
2022	34.5×	22.7×	35.4×
2021	30.0×	16.1×	30.0×
2020	20.7×	18.1×	33.1×
2019	29.5×	21.6×	34.3×
2018	29.5×	28.3×	58.4×
2017	28.2×	18.6×	31.8×
2016	18.2×	15.1×	19.8×
2015	19.4×	19.2×	81.2×
2014	76.3×	8.3×	78.8×
2013	8.4×	7.5×	15.9×
2012	11.6×	7.8×	12.2×
2011	9.6×	9.3×	15.1×

Against its peers

Companies in Medical - Care Facilities nearest Chemed's size, closest first, today.

Company	Price to free cash flow
CHEChemed	20.7×
PACSPACS	16.6×
SHCSotera Health	45.8×
CONConcentra Group Holdings Parent	18.7×
LFSTLifeStance Health	28.4×
OPCHOption Care Health	15.4×
ENSGEnsign	24.4×
UHSUniversal Health Services	13.0×
DVADavita	7.3×
BTSGBrightSpring Health Services	29.6×
NHCNational Healthcare	25.2×
Peer median	21.6×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Chemed

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.